PRKD3 and gastric cancer: More specifically, the aberrant expression of PRKD3 has been identified in cancer cells of various tumor types, including colorectal cancer (CRC), gastric cancer (GC), liver cancer (LC), prostate cancer (PC) and breast cancer (BC) [25,26,27,28,29].